DEF 14A Filing

Company

IGC Pharma, Inc.

Filed

July 23, 2010

Period of Report

August 16, 2010

Accession Number

0001185185-10-000817

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →